U.S. Durable Medical Equipment Market Size, Share & Trends Analysis Report By Product, By End Use, And Segment Forecasts, 2026 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. DME Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Regulatory Scenario
• 3.3. Reimbursement Scenario
• 3.4. Market Dynamics
  • 3.4.1. Market Driver Analysis
    • 3.4.1.1. Increasing prevalence of chronic diseases
    • 3.4.1.2. Rising geriatric population
    • 3.4.1.3. Technological advancements and growing AI integration
    • 3.4.1.4. Growing number of sports & road accidents coupled with the increasing number of injuries
    • 3.4.1.5. Favorable government initiatives
  • 3.4.2. Market Restraint Analysis
    • 3.4.2.1. High costs associated with durable medical equipment
    • 3.4.2.2. Lack of skilled professionals to handle this equipment
  • 3.4.3. Market Opportunity Analysis
    • 3.4.3.1. Growing demand for home healthcare services
    • 3.4.3.2. Improving reimbursement for durable medical equipment
    • 3.4.3.3. Rising production of medical equipment
    • 3.4.3.4. Growing accessibility and availability of medical equipment
    • 3.4.3.5. Increasing investments in medical
  • 3.4.4. Market Challenge Analysis
    • 3.4.4.1. Product recall
    • 3.4.4.2. Growing accessibility and availability of medical equipment
• 3.5. DME Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Bargaining power of suppliers
    • 3.5.1.2. Bargaining power of buyers
    • 3.5.1.3. Threat of substitutes
    • 3.5.1.4. Threat of new entrants
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political & Legal Landscape
    • 3.5.2.2. Economic and Social Landscape
    • 3.5.2.3. Technological landscape
  • 3.5.3. COVID-19 Impact Analysis
    • 3.5.3.1. Disrupted DME
    • 3.5.3.2. Obstacles in DME

Chapter 4. DME Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. DME Market: Product Movement Analysis & Market Share, 2025 & 2033
• 4.3. Personal Mobility Devices
  • 4.3.1. Personal Mobility Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Wheelchairs Market
    • 4.3.2.1 Wheelchairs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.2 Electric Wheelchairs Market
      • 4.3.2.2.1 Electric Wheelchairs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.3 Manual Wheelchairs Market
      • 4.3.2.3.1 Manual Wheelchairs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. Scooters Market
    • 4.3.3.1 Scooters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.4. Walker and Rollators Market
    • 4.3.4.1 Walker and Rollators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.5. Cranes and Crutches Market
    • 4.3.5.1 Cranes and Crutches Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.6. Door Openers Market
    • 4.3.6.1 Door Openers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.7. Other Devices Market
    • 4.3.7.1 Other Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Bathroom Safety Devices and Medical Furniture
  • 4.4.1. Bathroom Safety Devices and Medical Furniture Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Commodes and Toilets Market
    • 4.4.2.1 Commodes and Toilets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Mattress & Bedding Devices Market
    • 4.4.3.1 Mattress & Bedding Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Monitoring and Therapeutic Devices
  • 4.5.1. Monitoring and Therapeutic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Blood Sugar Monitors Market
    • 4.5.2.1 Blood Sugar Monitors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Continuous Passive Motion (CPM) Market
    • 4.5.3.1 Commodes and Toilets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. Infusion Pumps Market
    • 4.5.4.1 Infusion Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.5. Nebulizers Market
    • 4.5.5.1 Nebulizers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.6. Infusion Pumps Market
    • 4.5.6.1 Infusion Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.7. Oxygen Equipment Market
    • 4.5.7.1 Oxygen Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.8. Continuous Positive Airway Pressure (CPAP) Market
    • 4.5.8.1 Continuous Positive Airway Pressure (CPAP) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.9. Suction pumps Market
    • 4.5.9.1 Suction Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.10. Traction equipment Market
    • 4.5.10.1 Traction Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.11. Others Market
    • 4.5.11.1 Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11.2 Insulin Pumps Market
      • 4.5.11.2.1 Insulin Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11.3 Ostomy Bags & Accessories Market
      • 4.5.11.3.1 Ostomy Bags & Accessories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11.4 Wound Care Products Market
      • 4.5.11.4.1 Wound Care Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11.5 Cardiology Devices Market
      • 4.5.11.5.1 Cardiology Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11.6 Vital Signs Monitor Market
      • 4.5.11.6.1 Vital Signs Monitor Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11.7 Respiratory Supplies Market
      • 4.5.11.7.1 Respiratory Supplies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11.8 Urinary Supplies Market
      • 4.5.11.8.1 Urinary Supplies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11.9 Diabetic Supplies Market
      • 4.5.11.9.1 Diabetic Supplies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11.10 Incontinence Products Market
      • 4.5.11.10.1 Incontinence Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11.11 Orthopedic Braces & Support Market
      • 4.5.11.11.1 Orthopedic Braces & Support Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11.12 Muscle Stimulators Market
      • 4.5.11.12.1 Muscle Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11.13 Others Market
      • 4.5.11.13.1 Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. DME Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. DME Market: End Use Movement Analysis & Market Share, 2025 & 2033
• 5.3. Hospitals
  • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Specialty Clinics
  • 5.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Ambulatory Surgical Centers
  • 5.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Diagnostic Centers
  • 5.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Home Healthcare
  • 5.7.1. Home Healthcare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Market Participant Categorization
• 6.2. Key Company Profiles
  • 6.2.1. Invacare Corporation
    • 6.2.1.1. Company Overview
    • 6.2.1.2. Financial Performance
    • 6.2.1.3. Product Benchmarking
    • 6.2.1.4. Strategic Initiatives
  • 6.2.2. Sunrise Medical
    • 6.2.2.1. Company Overview
    • 6.2.2.2. Financial Performance
    • 6.2.2.3. Product Benchmarking
    • 6.2.2.4. Strategic Initiatives
  • 6.2.3. Arjo
    • 6.2.3.1. Company Overview
    • 6.2.3.2. Financial Performance
    • 6.2.3.3. Product Benchmarking
    • 6.2.3.4. Strategic Initiatives
  • 6.2.4. Medline Industries, Inc.
    • 6.2.4.1. Company Overview
    • 6.2.4.2. Financial Performance
    • 6.2.4.3. Product Benchmarking
    • 6.2.4.4. Strategic Initiatives
  • 6.2.5. GE HealthCare
    • 6.2.5.1. Company Overview
    • 6.2.5.2. Financial Performance
    • 6.2.5.3. Product Benchmarking
    • 6.2.5.4. Strategic Initiatives
  • 6.2.6. GF Healthcare Products, Inc.
    • 6.2.6.1. Company Overview
    • 6.2.6.2. Financial Performance
    • 6.2.6.3. Product Benchmarking
    • 6.2.6.4. Strategic Initiatives
  • 6.2.7. Carex Health Brands, Inc.
    • 6.2.7.1. Company Overview
    • 6.2.7.2. Financial Performance
    • 6.2.7.3. Product Benchmarking
    • 6.2.7.4. Strategic Initiatives
  • 6.2.8. Cardinal Health
    • 6.2.8.1. Company Overview
    • 6.2.8.2. Financial Performance
    • 6.2.8.3. Product Benchmarking
    • 6.2.8.4. Strategic Initiatives
  • 6.2.9. Drive DeVilbiss Healthcare
    • 6.2.9.1. Company Overview
    • 6.2.9.2. Financial Performance
    • 6.2.9.3. Product Benchmarking
    • 6.2.9.4. Strategic Initiatives
  • 6.2.10. NOVA Medical Products
    • 6.2.10.1. Company Overview
    • 6.2.10.2. Financial Performance
    • 6.2.10.3. Product Benchmarking
    • 6.2.10.4. Strategic Initiatives
  • 6.2.11. Kaye Products, Inc.
    • 6.2.11.1. Company Overview
    • 6.2.11.2. Financial Performance
    • 6.2.11.3. Product Benchmarking
    • 6.2.11.4. Strategic Initiatives
  • 6.2.12. Karman Healthcare, Inc.
    • 6.2.12.1. Company Overview
    • 6.2.12.2. Financial Performance
    • 6.2.12.3. Product Benchmarking
    • 6.2.12.4. Strategic Initiatives
  • 6.2.13. Numotion
    • 6.2.13.1. Company Overview
    • 6.2.13.2. Financial Performance
    • 6.2.13.3. Product Benchmarking
    • 6.2.13.4. Strategic Initiatives
  • 6.2.14. Pride Mobility Products Corporation
    • 6.2.14.1. Company Overview
    • 6.2.14.2. Financial Performance
    • 6.2.14.3. Product Benchmarking
    • 6.2.14.4. Strategic Initiatives
  • 6.2.15. Inogen, Inc.
    • 6.2.15.1. Company Overview
    • 6.2.15.2. Financial Performance
    • 6.2.15.3. Product Benchmarking
    • 6.2.15.4. Strategic Initiatives
  • 6.2.16. CAIRE, Inc.
    • 6.2.16.1. Company Overview
    • 6.2.16.2. Financial Performance
    • 6.2.16.3. Product Benchmarking
    • 6.2.16.4. Strategic Initiatives
  • 6.2.17. Portable Oxygen Solutions
    • 6.2.17.1. Company Overview
    • 6.2.17.2. Financial Performance
    • 6.2.17.3. Product Benchmarking
    • 6.2.17.4. Strategic Initiatives
  • 6.2.18. Rhythm Healthcare, LLC
    • 6.2.18.1. Company Overview
    • 6.2.18.2. Financial Performance
    • 6.2.18.3. Product Benchmarking
    • 6.2.18.4. Strategic Initiatives
  • 6.2.19. MedaCure Inc.
    • 6.2.19.1. Company Overview
    • 6.2.19.2. Financial Performance
    • 6.2.19.3. Product Benchmarking
    • 6.2.19.4. Strategic Initiatives
  • 6.2.20. Compass Health Brands
    • 6.2.20.1. Company Overview
    • 6.2.20.2. Financial Performance
    • 6.2.20.3. Product Benchmarking
    • 6.2.20.4. Strategic Initiatives
  • 6.2.21. Thermo Fisher Scientific, Inc.
    • 6.2.21.1. Company Overview
    • 6.2.21.2. Financial Performance
    • 6.2.21.3. Product Benchmarking
    • 6.2.21.4. Strategic Initiatives
  • 6.2.22. Abbott
    • 6.2.22.1. Company Overview
    • 6.2.22.2. Financial Performance
    • 6.2.22.3. Product Benchmarking
    • 6.2.22.4. Strategic Initiatives
  • 6.2.23. F. Hoffmann-La Roche Ltd.
    • 6.2.23.1. Company Overview
    • 6.2.23.2. Financial Performance
    • 6.2.23.3. Product Benchmarking
    • 6.2.23.4. Strategic Initiatives
  • 6.2.24. Medtronic
    • 6.2.24.1. Company Overview
    • 6.2.24.2. Financial Performance
    • 6.2.24.3. Product Benchmarking
    • 6.2.24.4. Strategic Initiatives
  • 6.2.25. Ascensia Diabetes Care Holdings AG
    • 6.2.25.1. Company Overview
    • 6.2.25.2. Financial Performance
    • 6.2.25.3. Product Benchmarking
    • 6.2.25.4. Strategic Initiatives
  • 6.2.26. Byram Healthcare Centers, Inc.
    • 6.2.26.1. Company Overview
    • 6.2.26.2. Financial Performance
    • 6.2.26.3. Product Benchmarking
    • 6.2.26.4. Strategic Initiatives
  • 6.2.27. Novo Nordisk
    • 6.2.27.1. Company Overview
    • 6.2.27.2. Financial Performance
    • 6.2.27.3. Product Benchmarking
    • 6.2.27.4. Strategic Initiatives
  • 6.2.28. Insulet Corporation
    • 6.2.28.1. Company Overview
    • 6.2.28.2. Financial Performance
    • 6.2.28.3. Product Benchmarking
    • 6.2.28.4. Strategic Initiatives
  • 6.2.29. Baxter
    • 6.2.29.1. Company Overview
    • 6.2.29.2. Financial Performance
    • 6.2.29.3. Product Benchmarking
    • 6.2.29.4. Strategic Initiatives
  • 6.2.30. B. Braun SE
    • 6.2.30.1. Company Overview
    • 6.2.30.2. Financial Performance
    • 6.2.30.3. Product Benchmarking
    • 6.2.30.4. Strategic Initiatives
  • 6.2.31. Micrel Medical Devices SA
    • 6.2.31.1. Company Overview
    • 6.2.31.2. Financial Performance
    • 6.2.31.3. Product Benchmarking
    • 6.2.31.4. Strategic Initiatives
  • 6.2.32. Boston Scientific Corporation
    • 6.2.32.1. Company Overview
    • 6.2.32.2. Financial Performance
    • 6.2.32.3. Product Benchmarking
    • 6.2.32.4. Strategic Initiatives
  • 6.2.33. Tandem Diabetes Care, Inc.
    • 6.2.33.1. Company Overview
    • 6.2.33.2. Financial Performance
    • 6.2.33.3. Product Benchmarking
    • 6.2.33.4. Strategic Initiatives
  • 6.2.34. BD
    • 6.2.34.1. Company Overview
    • 6.2.34.2. Financial Performance
    • 6.2.34.3. Product Benchmarking
    • 6.2.34.4. Strategic Initiatives
  • 6.2.35. Moog, Inc.
    • 6.2.35.1. Company Overview
    • 6.2.35.2. Financial Performance
    • 6.2.35.3. Product Benchmarking
    • 6.2.35.4. Strategic Initiatives
  • 6.2.36. IRadimed Corporation
    • 6.2.36.1. Company Overview
    • 6.2.36.2. Financial Performance
    • 6.2.36.3. Product Benchmarking
    • 6.2.36.4. Strategic Initiatives
  • 6.2.37. Koninklijke Philips N.V.
    • 6.2.37.1. Company Overview
    • 6.2.37.2. Financial Performance
    • 6.2.37.3. Product Benchmarking
    • 6.2.37.4. Strategic Initiatives
  • 6.2.38. Siemens Medical Solutions USA, Inc.
    • 6.2.38.1. Company Overview
    • 6.2.38.2. Financial Performance
    • 6.2.38.3. Product Benchmarking
    • 6.2.38.4. Strategic Initiatives
  • 6.2.39. Essity
    • 6.2.39.1. Company Overview
    • 6.2.39.2. Financial Performance
    • 6.2.39.3. Product Benchmarking
    • 6.2.39.4. Strategic Initiatives
  • 6.2.40. Coloplast Corporation
    • 6.2.40.1. Company Overview
    • 6.2.40.2. Financial Performance
    • 6.2.40.3. Product Benchmarking
    • 6.2.40.4. Strategic Initiatives
  • 6.2.41. Paul Hartmann AG
    • 6.2.41.1. Company Overview
    • 6.2.41.2. Financial Performance
    • 6.2.41.3. Product Benchmarking
    • 6.2.41.4. Strategic Initiatives
  • 6.2.42. Hollister Incorporated
    • 6.2.42.1. Company Overview
    • 6.2.42.2. Financial Performance
    • 6.2.42.3. Product Benchmarking
    • 6.2.42.4. Strategic Initiatives
  • 6.2.43. Convatec Group PLC
    • 6.2.43.1. Company Overview
    • 6.2.43.2. Financial Performance
    • 6.2.43.3. Product Benchmarking
    • 6.2.43.4. Strategic Initiatives
  • 6.2.44. Enovis Corporation
    • 6.2.44.1. Company Overview
    • 6.2.44.2. Financial Performance
    • 6.2.44.3. Product Benchmarking
    • 6.2.44.4. Strategic Initiatives
  • 6.2.45. Zynex, Inc.
    • 6.2.45.1. Company Overview
    • 6.2.45.2. Financial Performance
    • 6.2.45.3. Product Benchmarking
    • 6.2.45.4. Strategic Initiatives
  • 6.2.46. ZOLL Medical Corporation
    • 6.2.46.1. Company Overview
    • 6.2.46.2. Financial Performance
    • 6.2.46.3. Product Benchmarking
    • 6.2.46.4. Strategic Initiatives
  • 6.2.47. Ossur
    • 6.2.47.1. Company Overview
    • 6.2.47.2. Financial Performance
    • 6.2.47.3. Product Benchmarking
    • 6.2.47.4. Strategic Initiatives
  • 6.2.48. Breg, Inc.
    • 6.2.48.1. Company Overview
    • 6.2.48.2. Financial Performance
    • 6.2.48.3. Product Benchmarking
    • 6.2.48.4. Strategic Initiatives
  • 6.2.49. Bauerfeind USA, Inc.
    • 6.2.49.1. Company Overview
    • 6.2.49.2. Financial Performance
    • 6.2.49.3. Product Benchmarking
    • 6.2.49.4. Strategic Initiatives
  • 6.2.50. Biotronik
    • 6.2.50.1. Company Overview
    • 6.2.50.2. Financial Performance
    • 6.2.50.3. Product Benchmarking
    • 6.2.50.4. Strategic Initiatives
  • 6.2.51. AliMed
    • 6.2.51.1. Heat Company Overview
    • 6.2.51.2. Financial Performance
    • 6.2.51.3. Product Benchmarking
    • 6.2.51.4. Strategic Initiatives
• 6.3. Map Analysis/ Company Market Position Analysis
• 6.4. Estimated Company Market Share Analysis, 2025
• 6.5. List of Other Key Market Players

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 US DME Market, by Product, 2021 - 2033 (USD Million)
• Table 4 US DME Market, by End Use, 2021 - 2033 (USD Million)
• Table 5 Participant's Overview
• Table 6 Financial Performance
• Table 7 Service Benchmarking
• Table 8 Strategic Initiatives

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 DME Market, Market Segmentation
• Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 11 Porter's Five Forces Analysis
• Fig. 12 Country Marketplace: Key Takeaways
• Fig. 13 U.S. DME Market, 2021 - 2033 (USD Million)